The essential role of pharmacists in antibiotic stewardship in outpatient care: An official position statement of the Society of Infectious Diseases Pharmacists

被引：42

作者：

Blanchette, Lisa ^{[1
]}

Gauthier, Timothy ^{[2
]}

Heil, Emily ^{[3
]}

Klepser, Michael ^{[4
]}

Kelly, Karl Madaras ^{[5
]}

Nailor, Michael ^{[6
]}

Wei, Wenjing ^{[7
]}

Suda, Katie ^{[8
]}

机构：

[1] Novant Hlth Presbyterian Med Ctr, Charlotte, NC USA

[2] Miami Vet Affairs Healthcare Syst, Miami, FL USA

[3] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA

[4] Ferris State Univ, Coll Pharm, Big Rapids, MI USA

[5] Idaho State Univ, Coll Pharm, Meridian, ID USA

[6] St Josephs Hosp, Phoenix, AZ USA

[7] Parkland Hosp, Austin, TX USA

[8] Univ Illinois, Coll Pharm, Chicago, IL USA

来源：

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION | 2018年 / 58卷 / 05期

关键词：

CLOSTRIDIUM-DIFFICILE INFECTION; EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; ANTIMICROBIAL STEWARDSHIP; STREPTOCOCCAL PHARYNGITIS; RESISTANCE; PNEUMONIAE; SELECTION; SETTINGS; RATES;

D O I：

10.1016/j.japh.2018.05.013

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Objectives: The objective of this position statement is to describe the essential role of pharmacists in antimicrobial stewardship in outpatient care. Data sources: N/A. Summary: The majority of antibiotic prescribing occurs in outpatient care settings highlighting the need for antibiotic stewardship in the community. Given their expertise on medication management, pharmacists are essential to any antibiotic stewardship effort. Conclusion: As the regulations for antibiotic stewardship in outpatient settings continue to evolve and optimal stewardship strategies are defined, pharmacists must be leaders in the implementation of these programs. (C) 2018 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.

引用

页码：481 / 484

页数：4

共 50 条

[21] Position of the Infectious Diseases Society of America and the HIV Medicine Association on Team-based Infectious Diseases Care and the Roles of Advanced Practice Providers and Clinical Pharmacists
Balter, Laurence
Beieler, Alison M.
Burdette, Steven D.
Chakraborty, Rana
Ashley, Elizabeth Dodds
File, Tom
Haddad, Marwan
Keruly, Jeanne
Marcelin, Jasmine R.
Nelson, Sandra B.
Powderly, William
Rogers, Sara
Wheeler, David
Weddle, Andrea
CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 807 - 809
[22] Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Rybak, Michael J.
Lomaestro, Ben M.
Rotschafer, John C.
Moellering, Robert C., Jr.
Craig, William A.
Billeter, Marianne
Dalovisio, Joseph R.
Levine, Donald P.
PHARMACOTHERAPY, 2009, 29 (11): : 1275 - 1279
[23] Effect of on-call infectious-diseases pharmacists on antibiotic expenditures
Scheetz, MH
Postelnick, MJ
Scarsi, KK
Gerzenshtein, L
Bolon, MK
Fotis, M
Noskin, GA
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (19) : 1967 - 1968
[24] Expert clinical decision support systems to enhance antimicrobial stewardship programs - Insights from the society of infectious diseases pharmacists
Pestotnik, SL
PHARMACOTHERAPY, 2005, 25 (08): : 1116 - 1125
[25] Adding Antimicrobial Stewardship Pharmacists to the Infectious Diseases Compensation Discussion: A More Perfect Union?
Ryan, Keenan Levy
Jeffres, Meghan
Hornback, Krutika Mediwala
Lusardi, Katherine
Hirsch, Elizabeth B.
CLINICAL INFECTIOUS DISEASES, 2023, 79 (01) : 271 - 272
[26] Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper
Heil, Emily L.
Aitken, Samuel L.
Nix, David E.
Drew, Richard
Rose, Warren E.
Davis, Susan L.
Justo, Julie Ann
Fish, Douglas N.
Pogue, Jason M.
PHARMACOTHERAPY, 2020, 40 (04): : 368 - 371
[27] European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)
Schoffelen, Teske
Papan, Cihan
Carrara, Elena
Eljaaly, Khalid
Paul, Mical
Keuleyan, Emma
Quiros, Alejandro Martin
Peiffer-Smadja, Nathan
Palos, Carlos
May, Larissa
Pulia, Michael
Beovic, Bojana
Batard, Eric
Resman, Fredrik
Hulscher, Marlies
Schouten, Jeroen
CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (11) : 1384 - 1407
[28] Pharmacists leading the way in infectious diseases education, research, and patient care
Ashley, Elizabeth Dodds
Hielscher, Kayla R. Stover
Bookstaver, P. Brandon
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024,
[29] Antibiotic stewardship – Clinical infectious diseases in the intensive care unit
von Baum H.
Bracht H.
Der Pneumologe, 2016, 13 (5): : 331 - 337
[30] Bioterrorism: Pivotal clinical issues - Consensus review of the society of infectious diseases pharmacists
Terriff, CM
Schwartz, MD
Lomaestro, BM
PHARMACOTHERAPY, 2003, 23 (03): : 274 - 290

← 1 2 3 4 5 →